Transplant diagnostics involves assessing compatibility between organ donor and receiver so as to predict any future organ rejection episodes and have contingencies in place. Number of tests are performed such as ABO blood group compatibility, tissue typing, cross matching, panel reactive antibody test, serology screening, and testing for infectious diseases. Increased understanding of the organ rejection phenomenon has led to identification of robust biomarkers along with development of robust biomarker identification tests. Technological advancements in the molecular and non-molecular assays such as PCR, and NGS has increased the data throughput. However, high cost of transplant diagnostic products, limited medical reimbursement, and low awareness about organ transplantation in emerging economies such as Middle East and Asia Pacific is expected to be a factor hindering the transplant diagnostics market growth.
Market Dynamics
Rising prevalence of chronic diseases leading to multiple organ failures; benefits offered by transplant diagnostics, which can predict organ rejection episodes and help in preparing a contingency plan; increasing government initiatives for organ donation awareness; and research and development by leading players to enhance transplant diagnostic products is expected to boost growth of the transplant diagnostics market over the forecast period. For instance, Natera, Inc. and University of California, San Francisco (UCSF), announced a research collaboration in 2016, to study DNA markers of Kidney Transplant Rejection. Furthermore, in 2016, the U.S. government announced plans to invest US$ 200 million to shorten the waiting list of organ transplant patients. These factors are expected to aid in growth of the market over the forecast period.
Key features of the study:
- This report provides in-depth analysis of transplant diagnostics market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
- It profiles leading players in the global transplant diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Qiagen N.V., F. Hoffman-La Roche Ltd., Immucor, Inc., Becton Dickinson and Company, bioMérieux S.A., Illumina, Inc., CareDx, Inc., and GenDx.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The global transplant diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the transplant diagnostics market
Detailed Segmentation:
- Global Transplant Diagnostics Market, By Product Type:
- Instrument
- Reagents & Kits
- Software
- Global Transplant Diagnostics Market, By Technology:
- Molecular Assay
- PCR-Based
- Real Time PCR
- Sequence Specific Primer (SSP) PCR
- Sequence Specific Oligonucleotide (SSO) PCR
- Others
- Sequencing Based
- Sanger’s Sequencing
- Next Generation Sequencing (NGS)
- Others
- Non-Molecular Assay
- Serological Assay
- Mixed Lymphocyte Culture (MLC) Testing
- Flow Cytometry
- Global Transplant Diagnostics Market, By Application:
- Tissue Typing
- Infectious Disease Testing
- Serum-Cross Matching
- Blood Profiling
- Global Transplant Diagnostics Market, By Organ Type:
- Kidney
- Liver
- Heart
- Lungs
- Pancreas
- Others
- Global Transplant Diagnostics Market, By End User:
- Hospitals & Transplant Centers
- Research Laboratories & Academic Institutes
- Commercial Service Providers
- Global Transplant Diagnostics Market, By Geography:
- North America
- By Product Type:
- Instrument
- Reagents & Kits
- Software
- By Technology:
- Molecular Assay
- PCR-Based
- Real Time PCR
- Sequence Specific Primer (SSP) PCR
- Sequence Specific Oligonucleotide (SSO) PCR
- Others
- Sequencing Based
- Sanger’s Sequencing
- Next Generation Sequencing (NGS)
- Others
- Non-Molecular Assay
- Serological Assay
- Mixed Lymphocyte Culture (MLC)
- Flow Cytometry
- By Application:
- Tissue Typing
- Infectious Disease Testing
- Serum-Cross Matching
- Blood Profiling
- By Organ Type:
- Kidney
- Liver
- Heart
- Lungs
- Pancreas
- Others
- By End User:
- Hospitals & Transplant Centers
- Research Laboratories & Academic Institutes
- Commercial Service Providers
- By Country:
- Europe
- By Product Type:
- Instrument
- Reagents & Kits
- Software
- By Technology:
- Molecular Assay
- PCR-Based
- Real Time PCR
- Sequence Specific Primer (SSP) PCR
- Sequence Specific Oligonucleotide (SSO) PCR
- Others
- Sequencing Based
- Sanger’s Sequencing
- Next Generation Sequencing (NGS)
- Others
- Non-Molecular Assay
- Serological Assay
- Mixed Lymphocyte Culture (MLC)
- Flow Cytometry
- By Application:
- Tissue Typing
- Infectious Disease Testing
- Serum-Cross Matching
- Blood Profiling
- By Organ Type:
- Kidney
- Liver
- Heart
- Lungs
- Pancreas
- Others
- By End User:
- Hospitals & Transplant Centers
- Research Laboratories & Academic Institutes
- Commercial Service Providers
- By Country:
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Product Type:
- Instrument
- Reagents & Kits
- Software
- By Technology:
- Molecular Assay
- PCR-Based
- Real Time PCR
- Sequence Specific Primer (SSP) PCR
- Sequence Specific Oligonucleotide (SSO) PCR
- Others
- Sequencing Based
- Sanger’s Sequencing
- Next Generation Sequencing (NGS)
- Others
- Non-Molecular Assay
- Serological Assay
- Mixed Lymphocyte Culture (MLC)
- Flow Cytometry
- By Application:
- Tissue Typing
- Infectious Disease Testing
- Serum-Cross Matching
- Blood Profiling
- By Organ Type:
- Kidney
- Liver
- Heart
- Lungs
- Pancreas
- Others
- By End User:
- Hospitals & Transplant Centers
- Research Laboratories & Academic Institutes
- Commercial Service Providers
- By Country:
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- By Product Type:
- Instrument
- Reagents & Kits
- Software
- By Technology:
- Molecular Assay
- PCR-Based
- Real Time PCR
- Sequence Specific Primer (SSP) PCR
- Sequence Specific Oligonucleotide (SSO) PCR
- Others
- Sequencing Based
- Sanger’s Sequencing
- Next Generation Sequencing (NGS)
- Others
- Non-Molecular Assay
- Serological Assay
- Mixed Lymphocyte Culture (MLC)
- Flow Cytometry
- By Application:
- Tissue Typing
- Infectious Disease Testing
- Serum-Cross Matching
- Blood Profiling
- By Organ Type:
- Kidney
- Liver
- Heart
- Lungs
- Pancreas
- Others
- By End User:
- Hospitals & Transplant Centers
- Research Laboratories & Academic Institutes
- Commercial Service Providers
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- By Product Type:
- Instrument
- Reagents & Kits
- Software
- By Technology:
- Molecular Assay
- PCR-Based
- Real Time PCR
- Sequence Specific Primer (SSP) PCR
- Sequence Specific Oligonucleotide (SSO) PCR
- Others
- Sequencing Based
- Sanger’s Sequencing
- Next Generation Sequencing (NGS)
- Others
- Non-Molecular Assay
- Serological Assay
- Mixed Lymphocyte Culture (MLC)
- Flow Cytometry
- By Application:
- Tissue Typing
- Infectious Disease Testing
- Serum-Cross Matching
- Blood Profiling
- By Organ Type:
- Kidney
- Liver
- Heart
- Lungs
- Pancreas
- Others
- By End User:
- Hospitals & Transplant Centers
- Research Laboratories & Academic Institutes
- Commercial Service Providers
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Product Type:
- Instrument
- Reagents & Kits
- Software
- By Technology:
- Molecular Assay
- PCR-Based
- Real Time PCR
- Sequence Specific Primer (SSP) PCR
- Sequence Specific Oligonucleotide (SSO) PCR
- Others
- Sequencing Based
- Sanger’s Sequencing
- Next Generation Sequencing (NGS)
- Others
- Non-Molecular Assay
- Serological Assay
- Mixed Lymphocyte Culture (MLC)
- Flow Cytometry
- By Application:
- Tissue Typing
- Infectious Disease Testing
- Serum-Cross Matching
- Blood Profiling
- By Organ Type:
- Kidney
- Liver
- Heart
- Lungs
- Pancreas
- Others
- By End User:
- Hospitals & Transplant Centers
- Research Laboratories & Academic Institutes
- Commercial Service Providers
- By Country:
- Central Africa
- South Africa
- North Africa
- Company Profiles
- Thermo Fisher Scientific, Inc.*
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments
- Bio-Rad Laboratories, Inc.
- Qiagen N.V.
- Hoffman-La Roche Ltd.
- Immucor, Inc.
- Becton Dickinson and Company
- BioMérieux S.A.
- Illumina, Inc.
- CareDx, Inc.
- GenDx
“*” marked represents similar segmentation in other categories in the respective section.
Table of Content - Transplant Diagnostics Market
